These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9713917)

  • 1. Kinetics of Chlamydia trachomatis clearance in patients with azithromycin, as assessed by first void urine testing by PCR and transcription-mediated amplification.
    Bianchi A; Bogard M; Cessot G; Bohbot JM; Malkin JE; Alonso JM
    Sex Transm Dis; 1998 Aug; 25(7):366-7. PubMed ID: 9713917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polymerase chain reaction in the detection of patients infected by Chlamydia trachomatis after treatment].
    Wang H; Wang J; Liu Y
    Zhonghua Yi Xue Za Zhi; 1997 Feb; 77(2):91-3. PubMed ID: 9596935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to clearance of Chlamydia trachomatis RNA and DNA after treatment in patients coinfected with Neisseria gonorrhoeae - a prospective cohort study.
    Wind CM; Schim van der Loeff MF; Unemo M; Schuurman R; van Dam AP; de Vries HJ
    BMC Infect Dis; 2016 Oct; 16(1):554. PubMed ID: 27724878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A school-based Chlamydia control program using DNA amplification technology.
    Cohen DA; Nsuami M; Etame RB; Tropez-Sims S; Abdalian S; Farley TA; Martin DH
    Pediatrics; 1998 Jan; 101(1):E1. PubMed ID: 9417165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia trachomatis variant not detected by plasmid based nucleic acid amplification tests: molecular characterisation and failure of single dose azithromycin.
    Magbanua JP; Goh BT; Michel CE; Aguirre-Andreasen A; Alexander S; Ushiro-Lumb I; Ison C; Lee H
    Sex Transm Infect; 2007 Jul; 83(4):339-43. PubMed ID: 17567684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.
    Deguchi T; Hatazaki K; Ito S; Kondo H; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M
    J Infect Chemother; 2018 Aug; 24(8):610-614. PubMed ID: 29627327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy.
    Gaydos CA; Crotchfelt KA; Howell MR; Kralian S; Hauptman P; Quinn TC
    J Infect Dis; 1998 Feb; 177(2):417-24. PubMed ID: 9466530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity.
    Mahony J; Chong S; Jang D; Luinstra K; Faught M; Dalby D; Sellors J; Chernesky M
    J Clin Microbiol; 1998 Nov; 36(11):3122-6. PubMed ID: 9774550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between culture testing of swabs and ligase chain reaction of first void urine from patients recently treated for Chlamydia trachomatis.
    Jang D; Sellors J; Howard M; Mahony J; Frost E; Patrick D; Bouchard C; Dubois J; Scholar L; Chernesky M
    Sex Transm Infect; 2003 Jun; 79(3):237-9. PubMed ID: 12794211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin in the management of Chlamydia trachomatis infections.
    Ridgway GL
    Int J STD AIDS; 1996; 7 Suppl 1():5-8. PubMed ID: 8652727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure).
    Dukers-Muijrers NHTM; Wolffs PFG; De Vries H; Götz HM; Heijman T; Bruisten S; Eppings L; Hogewoning A; Steenbakkers M; Lucchesi M; Schim van der Loeff MF; Hoebe CJPA
    Clin Infect Dis; 2019 Nov; 69(11):1946-1954. PubMed ID: 30689759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.
    Manavi K; Hettiarachchi N; Hodson J
    Int J STD AIDS; 2016 Dec; 27(14):1303-1308. PubMed ID: 26511655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia trachomatis infections: progress and problems.
    Stamm WE
    J Infect Dis; 1999 Mar; 179 Suppl 2():S380-3. PubMed ID: 10081511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification.
    Morré SA; Sillekens PT; Jacobs MV; de Blok S; Ossewaarde JM; van Aarle P; van Gemen B; Walboomers JM; Meijer CJ; van den Brule AJ
    Mol Pathol; 1998 Jun; 51(3):149-54. PubMed ID: 9850338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women.
    Genç M; Mårdh A
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):1-7. PubMed ID: 7503471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
    Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
    DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of asymptomatic rectal Chlamydia trachomatis: is single-dose azithromycin effective?
    Steedman NM; McMillan A
    Int J STD AIDS; 2009 Jan; 20(1):16-8. PubMed ID: 19103887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the FemCure study: prospective multicentre study on the transmission of genital and extra-genital Chlamydia trachomatis infections in women receiving routine care.
    Dukers-Muijrers NH; Wolffs PF; Eppings L; Götz HM; Bruisten SM; Schim van der Loeff MF; Janssen K; Lucchesi M; Heijman T; van Benthem BH; van Bergen JE; Morre SA; Herbergs J; Kok G; Steenbakkers M; Hogewoning AA; de Vries HJ; Hoebe CJ
    BMC Infect Dis; 2016 Aug; 16():381. PubMed ID: 27502928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questioning azithromycin for chlamydial infection.
    Handsfield HH
    Sex Transm Dis; 2011 Nov; 38(11):1028-9. PubMed ID: 21992978
    [No Abstract]   [Full Text] [Related]  

  • 20. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.
    Lea AP; Lamb HM
    Pharmacoeconomics; 1997 Nov; 12(5):596-611. PubMed ID: 10174326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.